AR072685A1 - Composicion topica para el tratamiento de queratosis actinica - Google Patents
Composicion topica para el tratamiento de queratosis actinicaInfo
- Publication number
- AR072685A1 AR072685A1 ARP090102493A ARP090102493A AR072685A1 AR 072685 A1 AR072685 A1 AR 072685A1 AR P090102493 A ARP090102493 A AR P090102493A AR P090102493 A ARP090102493 A AR P090102493A AR 072685 A1 AR072685 A1 AR 072685A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- actinic keratosis
- topical composition
- active agent
- keratosis
- Prior art date
Links
- 208000009621 actinic keratosis Diseases 0.000 title abstract 3
- 230000000699 topical effect Effects 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract 2
- 229960002949 fluorouracil Drugs 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract 1
- 229960004889 salicylic acid Drugs 0.000 abstract 1
- 229940042129 topical gel Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Una composicion de gel topica que comprende (a) un agente activo para el tratamiento de queratosis actínica, como por ejemplo S'-fluorouracilo, (b) un agente queratolíticamente activo, como por ejemplo ácido salicílico, (c) un formador de gel y (d) un solvente orgánico para su uso en el tratamiento de queratosis actínica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08012237A EP2143421A1 (en) | 2008-07-07 | 2008-07-07 | Topical composition for the treatment of actinic keratosis |
Publications (1)
Publication Number | Publication Date |
---|---|
AR072685A1 true AR072685A1 (es) | 2010-09-15 |
Family
ID=40039993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090102493A AR072685A1 (es) | 2008-07-07 | 2009-07-03 | Composicion topica para el tratamiento de queratosis actinica |
Country Status (32)
Country | Link |
---|---|
US (1) | US8569320B2 (es) |
EP (2) | EP2143421A1 (es) |
JP (2) | JP5654987B2 (es) |
KR (1) | KR101689898B1 (es) |
CN (2) | CN102088957A (es) |
AR (1) | AR072685A1 (es) |
AU (1) | AU2009267471B2 (es) |
BR (1) | BRPI0915439B8 (es) |
CA (1) | CA2729974A1 (es) |
CL (1) | CL2010001642A1 (es) |
CO (1) | CO6351710A2 (es) |
CY (1) | CY1116111T1 (es) |
DK (1) | DK2315581T3 (es) |
EA (1) | EA019533B1 (es) |
EC (1) | ECSP11010762A (es) |
ES (1) | ES2532948T3 (es) |
HK (1) | HK1154793A1 (es) |
HR (1) | HRP20150222T1 (es) |
IL (1) | IL210134A (es) |
ME (1) | ME02147B (es) |
MX (1) | MX2011000054A (es) |
MY (1) | MY158428A (es) |
NZ (1) | NZ590288A (es) |
PE (1) | PE20110330A1 (es) |
PL (1) | PL2315581T3 (es) |
PT (1) | PT2315581E (es) |
RS (1) | RS53887B1 (es) |
SI (1) | SI2315581T1 (es) |
TW (1) | TWI433692B (es) |
UA (1) | UA101044C2 (es) |
WO (1) | WO2010003568A1 (es) |
ZA (1) | ZA201100653B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2485720B1 (en) * | 2009-10-08 | 2018-08-22 | Bayer Consumer Care AG | Low ether composition and delivery apparatus |
JP5950528B2 (ja) * | 2011-09-30 | 2016-07-13 | 小林製薬株式会社 | 皮膜形成性外用製剤 |
US20140322310A1 (en) * | 2011-12-12 | 2014-10-30 | Leo Laboratories Limited | Gel compositions |
NZ606177A (en) * | 2012-01-30 | 2014-03-28 | Dolorgiet Gmbh & Co Kg | Compositions for the treatment of actinic keratosis |
GB201222405D0 (en) * | 2012-12-12 | 2013-01-23 | Leo Lab Ltd | Gel compositions |
EP3174601A4 (en) | 2014-07-31 | 2018-01-10 | Sun Pharmaceutical Industries Ltd | Oral pharmaceutical composition of isotretinoin |
DK3010511T3 (en) | 2014-09-12 | 2018-03-05 | Antibiotx As | ANTIBACTERIAL USE OF HALOGENERED SALICYLANILIDES |
GB201509326D0 (en) | 2015-05-29 | 2015-07-15 | Antibio Tx Aps | Novel use |
PL3319637T3 (pl) * | 2015-07-10 | 2023-03-20 | Infectopharm Arzneimittel Und Consilium Gmbh | Zastosowanie wodorotlenku potasu w leczeniu rogowacenia słonecznego |
GB201604484D0 (en) * | 2016-03-16 | 2016-04-27 | Antibiotx Aps And Københavns Uni University Of Copenhagen | Topical antibacterial compositions |
KR20190141661A (ko) | 2017-03-10 | 2019-12-24 | 아테넥스, 인크. | 광선 각화증의 치료 및/또는 예방 방법 |
US11419834B2 (en) | 2019-02-25 | 2022-08-23 | Rhode Island Hospital | Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide |
US20220175769A1 (en) * | 2020-12-08 | 2022-06-09 | Ankh Life Sciences Limited | Method of treatment of actinic keratoses |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2802005A (en) | 1957-08-06 | S-eluorourace | ||
US4234599A (en) * | 1978-10-04 | 1980-11-18 | Scott Eugene J Van | Treatment of skin keratoses with α-hydroxy acids and related compounds |
US5091171B2 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use |
US5167649A (en) * | 1988-08-22 | 1992-12-01 | Zook Gerald P | Drug delivery system for the removal of dermal lesions |
US5093360A (en) * | 1989-04-07 | 1992-03-03 | Yu Ruey J | Retinal, derivatives and their therapeutic use |
GB9023701D0 (en) * | 1990-10-31 | 1990-12-12 | Efamol Holdings | Medical treatment |
JP3117502B2 (ja) * | 1991-08-27 | 2000-12-18 | 株式会社資生堂 | 皮膚外用剤 |
US5627187A (en) | 1995-04-12 | 1997-05-06 | Katz; Bruce E. | 5-FU for treating actinic kerotoses |
HU0200901D0 (es) * | 1996-06-20 | 2002-08-28 | Lavipharm Sa | |
US5993787A (en) * | 1996-09-13 | 1999-11-30 | Johnson & Johnson Consumer Products, Inc. | Composition base for topical therapeutic and cosmetic preparations |
US5955097A (en) * | 1996-10-18 | 1999-09-21 | Virotex Corporation | Pharmaceutical preparation applicable to mucosal surfaces and body tissues |
US6462071B1 (en) * | 2000-03-02 | 2002-10-08 | Vitreo-Retinal Technologies, Inc. | Agents for intravitreal administration to treat or prevent disorders of the eye |
ES2223277B1 (es) * | 2003-06-19 | 2006-03-01 | Fernando Bouffard Fita | Composicion anestesica para administracion topica. |
US20050075407A1 (en) * | 2003-08-25 | 2005-04-07 | Foamix Ltd. | Foam incorporating eutetic mixture |
WO2005027977A2 (en) * | 2003-09-22 | 2005-03-31 | Agis Industries (1983) Ltd. | Diclofenac compositions for the treatment of skin disorders |
JP5324091B2 (ja) * | 2004-06-24 | 2013-10-23 | アイデックス ラボラトリーズ,インコーポレイティド | 薬物送達のための医薬組成物及びそれを使用する症状の治療又は予防法 |
US20070053984A1 (en) | 2005-03-03 | 2007-03-08 | Monique Spann-Wade | Topical gels compositions |
EP1890687B1 (en) * | 2005-06-14 | 2008-09-17 | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. | Stable pharmaceutical gel of diclofenac sodium |
US7851431B2 (en) * | 2005-07-27 | 2010-12-14 | Prescription Dispensing Laboratories | Treatment of actinic keratoses with calcium channel blockers |
US20070264317A1 (en) * | 2006-05-15 | 2007-11-15 | Perrigo Israel Pharmaceuticals Ltd. | Imiquimod cream formulation |
WO2008047857A1 (fr) * | 2006-10-18 | 2008-04-24 | Fujifilm Corporation | Procédé de production d'une composition comprenant un composé difficilement soluble dans l'eau incorporé dans une matrice hydrophile et préparation pour une utilisation externe comprenant un agent ou médicament anticancéreux ayant un coefficient de partage octanol/eau (log p) de -3,0 ou plus mais pas plus de 3,0, incorporé |
-
2008
- 2008-07-07 EP EP08012237A patent/EP2143421A1/en not_active Withdrawn
-
2009
- 2009-06-29 PT PT97768766T patent/PT2315581E/pt unknown
- 2009-06-29 MY MYPI2011000028A patent/MY158428A/en unknown
- 2009-06-29 PE PE2010001215A patent/PE20110330A1/es not_active Application Discontinuation
- 2009-06-29 JP JP2011516999A patent/JP5654987B2/ja active Active
- 2009-06-29 WO PCT/EP2009/004682 patent/WO2010003568A1/en active Application Filing
- 2009-06-29 AU AU2009267471A patent/AU2009267471B2/en active Active
- 2009-06-29 NZ NZ590288A patent/NZ590288A/xx unknown
- 2009-06-29 SI SI200931142T patent/SI2315581T1/sl unknown
- 2009-06-29 RS RS20150185A patent/RS53887B1/en unknown
- 2009-06-29 ME MEP-2015-38A patent/ME02147B/me unknown
- 2009-06-29 UA UAA201101405A patent/UA101044C2/ru unknown
- 2009-06-29 MX MX2011000054A patent/MX2011000054A/es active IP Right Grant
- 2009-06-29 CA CA2729974A patent/CA2729974A1/en not_active Abandoned
- 2009-06-29 PL PL09776876T patent/PL2315581T3/pl unknown
- 2009-06-29 EP EP09776876.6A patent/EP2315581B1/en active Active
- 2009-06-29 CN CN2009801266635A patent/CN102088957A/zh active Pending
- 2009-06-29 KR KR1020117002825A patent/KR101689898B1/ko active IP Right Grant
- 2009-06-29 DK DK09776876T patent/DK2315581T3/en active
- 2009-06-29 ES ES09776876.6T patent/ES2532948T3/es active Active
- 2009-06-29 US US13/002,971 patent/US8569320B2/en active Active
- 2009-06-29 CN CN201510185320.3A patent/CN104825384A/zh active Pending
- 2009-06-29 BR BRPI0915439A patent/BRPI0915439B8/pt active IP Right Grant
- 2009-06-29 EA EA201100020A patent/EA019533B1/ru unknown
- 2009-07-03 AR ARP090102493A patent/AR072685A1/es unknown
- 2009-07-06 TW TW098122756A patent/TWI433692B/zh active
-
2010
- 2010-12-20 IL IL210134A patent/IL210134A/en active IP Right Grant
- 2010-12-30 CL CL2010001642A patent/CL2010001642A1/es unknown
-
2011
- 2011-01-17 EC ECSP11010762 patent/ECSP11010762A/es unknown
- 2011-01-26 ZA ZA2011/00653A patent/ZA201100653B/en unknown
- 2011-02-07 CO CO11013458A patent/CO6351710A2/es not_active Application Discontinuation
- 2011-08-29 HK HK11109094.3A patent/HK1154793A1/xx unknown
-
2014
- 2014-10-16 JP JP2014211989A patent/JP2015038129A/ja not_active Withdrawn
-
2015
- 2015-02-26 HR HRP20150222TT patent/HRP20150222T1/hr unknown
- 2015-03-13 CY CY20151100254T patent/CY1116111T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR072685A1 (es) | Composicion topica para el tratamiento de queratosis actinica | |
CL2009000393A1 (es) | Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular. | |
ES2487496T3 (es) | Agente para aliviar el síndrome metabólico | |
AR048878A1 (es) | Composiciones topicas de metadona y metodos para usarlas | |
CL2008000442A1 (es) | Composicion farmaceutica que comprende a un quitosano, un ingrediente activo cosmetico o farmaceutico, y un solvente volatil; y su uso para tratar psoriasis, micosis entre otras enfermedades. | |
BR112014027039A2 (pt) | formulação farmacêutica tópica não aquosa; uso de formulação farmacêutica não aquosa; formulação não aquosa; e método | |
BR112013018352A2 (pt) | composição de minociclina tópica e método | |
CL2010000188A1 (es) | Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso. | |
ATE489048T1 (de) | Vorrichtung für kombinierte behandlung | |
NI201100082A (es) | Compuestos de isoindolina para uso en el tratamiento de cáncer. | |
AR060165A1 (es) | Proteina de suero como vehiculo de entrega para un agente activo | |
GT200600520A (es) | Agentes antibacterianos | |
CL2012000446A1 (es) | Uso de una formulación vesicular tópica que comprende uno o más fosfolípidos y uno o más tensoactivos en una razón molar de 1:1 a 25:1 de fosfolípidos a tensoactivos, para el tratamiento de trastornos dermatosos inflamatorios. | |
EA201071166A1 (ru) | Контролируемое высвобождение активных агентов из олеосом | |
BRPI0518869A2 (pt) | agentes citotàxicos compreendendo taxanos | |
UY30158A1 (es) | Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor | |
CL2011003327A1 (es) | Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales. | |
AR082155A1 (es) | Formulacion antiseptica y desinfectante que tiene contenido de yodo reducido | |
CL2009001841A1 (es) | Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto. | |
AR057648A1 (es) | Composicion de metaflumizona para la administracion topica | |
BR112012015437A2 (pt) | composição tópica substancialmente anidra de armazenamento estável | |
CL2008002758A1 (es) | Composicion que comprende al menos un principio activo laxante y al menos un principio activo antiespumante; uso para el tratamiento del estrenimiento. | |
CL2009000665A1 (es) | Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas. | |
AR052048A1 (es) | Composiciones farmaceuticas para el tratamiento de la celulitis | |
ECSP15003613A (es) | Formulación transdérmica que contiene inhibidores de cox |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |